AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Eosinopenia in Severe COPD Exacerbation

Recruitingn/aAges 35 Years - anyAllNorthumbria Healthcare NHS Foundation Trust
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goals of this observational study are to identify factors independently associated with admission eosinopenia in patients with a severe exacerbation of chronic obstructive pulmonary disease (COPD) and to determine when blood eosinophil count (BEC) will recover to baseline stable state in patients who are admitted to hospital with a severe exacerbation of COPD and associated eosinopenia. The main aims of the study are to: 1. Identify demographic, physiological and clinical factors independently associated with admission eosinopenia in patients with a severe exacerbation of COPD 2. Assess the time to recovery from eosinopenia to stable BEC following a severe exacerbation of COPD

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Admitted to hospital with primary clinical diagnosis of exacerbation of COPD\* * Smoking history of at least 10 pack years * Airflow obstruction: FEV1/FVC ratio \< 0.7 confirmed on historic or inpatient spirometry * Capacity to give informed consent to participate Exclusion Criteria: * Parasitic infection, systemic fungal infection (excluding infection limited to nails or skin), eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome or other conditions associated with a high eosinophil count# * Active malignancy * Maintenance oral prednisolone or other systemic steroids, anti-interleukin 5 therapy or other medication known to influence eosinophils * Patients with poor venous access * Investigator confirmed history of asthma * Non-COPD related health problems which in the view of the primary investigator may compromise the conduct and completion of the study ADDITIONAL CRITERIA FOR THE TIME TO RECOVERY FROM EOSINOPENIA ANALYSIS ONLY Inclusion criteria: * Eosinopenia on admission * Uneventful recovery\* * Eosinopenia on admission who do not receive a further course of systemic corticosteroids or require emergency hospital admission for an acute illness in the six weeks following admission to hospital with a severe exacerbation of COPD.
๐Ÿ’Š

What it tests

  • Blood eosinophil count
๐Ÿ“

Where

1 site
Northumbria Healthcare NHS Foundation Trust
North Shields, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy